Chughtai M.,Rubin Institute for Advanced Orthopedics |
Mont M.A.,Rubin Institute for Advanced Orthopedics |
Cherian C.,Rubin Institute for Advanced Orthopedics |
Elmallah R.D.K.,Rubin Institute for Advanced Orthopedics |
And 3 more authors.
Journal of Knee Surgery | Year: 2016
Introduction Certain patients continue to suffer from knee stiffness following total knee arthroplasty (TKA) despite undergoing conventional therapies. Astym therapy to these patients may offer an effective, safe, nonoperative treatment. This study evaluates the effects of Astym therapy upon (1) range of motion and (2) subjective functional improvements in post-TKA patients who suffered from stiffness recalcitrant to other nonoperative interventions. Methods Twenty-three post-TKA patients (29 knees) who had recalcitrant knee stiffness were included in this study. Pre- and post-Astym improvements in range of motion and Knee Society scores were compared. We analyzed knees based on the presence of flexion deficit or contracture. Further stratification was made into knees that received Astym therapy before and after a 3-month period of standard rehabilitation. Differences in range of motion from pre- to post-Astym were evaluated by measuring (1) degree of flexion deficit or contracture and (2) total arc of passive motion. Improvements in subjective functional status were determined by evaluating Knee Society scores pre- and post-Astym therapy. A two-tailed Student t-test was used to compare weighted mean differences from pre- to post-Astym for the above parameters. Results The mean flexion deficit improved significantly (p < 0.001) in all patients after Astym therapy. The mean flexion contracture improved significantly in (p = 0.001) in 91% of patients after Astym therapy. Knees with flexion deficits or contractures both improved in total arc of motion when compared with pretherapy. Overall, patients who underwent treatment with Astym therapy reported significant mean improvements in both Knee Society objective (80 vs. 57 points; p < 0.0001) and functional scores (80 vs. 54 points; p = 0.0003) when compared with their pretherapy objective and functional scores. No harms were reported. Conclusion Astym therapy is a novel, nonoperative treatment that may be an effective treatment option for post-TKA patients suffering from persistent knee stiffness. Further studies are needed to validate this intervention as a part of cost-effective, standard treatment after TKA. © 2016 by Thieme Medical Publishers, Inc.
News Article | December 1, 2016
The International Association of HealthCare Professionals is pleased to welcome Robert Werblin, MD, Emergency Medicine Physician, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified emergency medicine physician with a vast expertise in all facets of his work, especially emergency training and pediatric and adult critical care. Dr. Werblin has been in practice for 40 years and is currently serving patients as the Director of Emergency Services at River Hospital in Alexandria Bay, New York. In 1971, Dr. Werblin received his Medical Degree from Albany Medical College, prior to training at Children’s Hospital and Albany Medical Center in Pediatric Intensive Care, Emergency Training, and Pediatric Cardiology. While he was completing his Pediatric Cardiology training, a fraction of his time was also spent training in Adult Cardiology. Furthermore, Dr. Werblin holds dual board certification by both the American Board of Emergency Medicine and the American Board of Pediatrics. Prior to being full time in Emergency Medicine, Dr. Werblin managed a critical care unit for children and adults that had just undergone open-heart surgery, and also served as the Director of Ped-Adolescent Critical Care at New Beth Israel Medical Center, College of Medicine & Dentistry in Newark, New Jersey. He feels that he owes his successful career to his great mentors, his passion for helping others, making a difference, and research. When he is not assisting patients, Dr. Werblin enjoys listening to music, attending Broadway shows, athletics, and spending time with his family and friends. Learn more about Dr. Werblin by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit:http://www.findatopdoc.com
News Article | December 14, 2016
Dr. Neema Pourtaheri joins SRO’s team of board-certified and fellowship trained subspecialists who together combine extensive knowledge and experience with state-of-the-art surgical techniques. The expanded team of SRO professionals includes; medical assistants, physical and occupational therapists and staff who all work together to ensure that each patient benefits from an extraordinary continuum of care that only SRO can provide. Dr. Pourtaheri completed his undergraduate degree in Biomedical Engineering from the University of California, Berkeley before earning a Medical Doctorate in New Orleans, Louisiana, at Tulane University School of Medicine. Dr. Pourtaheri was appointed Chief Resident in his final year as Orthopaedic Surgery Residency at St. Joseph Regional Medical Center. He then went on to advance his orthopaedic expertise with a shoulder and elbow Fellowship at Beth Israel Medical Center in New York. While pursuing undergraduate studies, residency and fellowship, Dr. Pourtaheri published several lauded works on orthopaedic conditions and treatments. Dr. Pourtaheri is also Board Certified by the American Board of Orthopaedic Surgery and a member of the Arthroscopic Association of North America (AANA) and the American Academy of Orthopaedic Surgeons (AAOS). He has trained alongside some of the world’s finest orthopaedic surgeons and brings invaluable medical expertise pertaining to the latest advancements in shoulder and elbow care. The overall scope of Dr. Pourtaheri’s practice includes; In any orthopedic situation, the goal of the SRO Team is to enhance mobility, diminish pain, increase function, achieve independence and improve quality of life for patients. Along with Dr. Pourtaheri the SRO team continues to implement the latest advances with increased expertise in shoulder and elbow diagnosis, treatment, and rehabilitation. An important part of maintaining an active, healthy lifestyle is having flexibility and mobility in the shoulder and elbow joints. Nagging symptoms such as chronic pain and arthritis that limit mobility can cause a person to refrain from fully participating in life’s simple pleasures. This can also lead to depression and a whole host of health issues that follow. Dr. Pourtaheri offers a variety of non-surgical and surgical treatment options aimed at helping patients resume the activities that make life meaningful. The cause of painful shoulder and elbow complaints can be quite varied and include; osteoarthritis, rheumatoid arthritis, post-traumatic injury stemming from an accident or fall, and more. While pain sometimes can be treated at home with rest, ice and over-the-counter medication, more severe shoulder injuries and conditions require an orthopedist for diagnosis and treatment. Common conditions can include; arthritis, shoulder bone spurs, torn rotator cuffs, fractures, dislocation, damaged cartilage, throwing injuries, and more. SRO offers patients in-house diagnostic imaging, rehabilitation, sports injury prevention, as well as advanced surgical treatments in joint replacement, sports medicine, trauma care, hand, foot and ankle, shoulder and elbow and general orthopedic surgery. To learn more visit the SRO website and to make an appointment with Dr. Pourtaheri call 707-546-1922.
News Article | November 24, 2016
To help kick off the holiday season, the Boca Raton community came together earlier this month for the second biennial ‘Grow to Give’ event, which benefits men, women and children suffering from cancer-related hair loss. This year, 30 participants, which included both adults and children, celebrated the spirit of giving with a ‘cut that heals.’ Over 300 inches of hair were donated to Locks of Love and Pantene Beautiful Lengths, where they will be used to make wigs and cranial prosthetics for cancer patients. The event, which took place on November 6th, was hosted by Congregation B’nai Israel. This life-changing program was created and designed by Rabbi Marci R. Bloch after encountering multiple congregation members and families affected by cancer. In addition to the hair donations, money was also raised for cancer research and other local charities. Dr. Alan J. Bauman, a prominent hair restoration physician and founder of Bauman Medical in Boca Raton, was a VIP sponsor for this year’s event through his 501(c)(3) non-profit organization, the Bauman Philanthropic Foundation. “For many cancer patients, hair loss is a painful reality—a trigger of intense emotions and a daily reminder of the health situation that often seems out of their control,” he explained. “It was such an honor to be part of the ‘Grow to Give’ event. It was a really special way to start the holiday season, by seeing the community come together for a great cause. Because of their generosity, we will be able to give so many patients a much needed boost, by helping them restore their hair both during and after treatment.” Dr. Bauman has a long history of award winning philanthropic involvement in the community, and often supports various charitable groups, organizations and events in the areas of education and healthcare in additional to local community initiatives. Thanks to the support of local sponsors, each participant was treated to a special cut and style from one of the many hairstylists who volunteered their talents for the cause. “We wanted to really acknowledge what a special gift these donors were giving by treating them to a little pampering,” explained Dr. Bauman. “Because what they were doing was so much more than just a haircut.” View photos from the event at http://hai.rs/grow2give2016 The event also was an opportunity to raise awareness on new cranial prosthetics, one of the most exciting breakthroughs in hair restoration, which are proving to be an especially valuable tool for treating chemo-induced hair loss. “These advanced hair replacement systems have the ability to dramatically improve the quality of life for men and women who are not candidates for transplantation and other medical treatments due to chemotherapy or other cancer treatments,” asserted Dr. Bauman. A leading product in the cranial prosthetic category, the CRLab CNC Cranial Prosthesis is a unique medical-grade hair and scalp replacement system which uses 3D printing to perfectly design and conform the prosthetic or second skin to the patient’s exact cranial measurements, skin type and other specifications. To learn more about CNC hair and scalp cranial prosthesis as an option for cancer-related hair loss, visit http://www.baumanmedical.com/3d-printed-hair. If you or someone you know is suffering from cancer-related hair loss, schedule a long-distance phone consultation or an in-person, in-office consultation with Dr. Bauman online at http://www.baumanmedical.com or by calling toll-free 844-GET-HAIR or +1-561-394-0024. About the Bauman Philanthropic Foundation: Continuing an almost twenty-year benevolent tradition of Bauman Medical, the Bauman Philanthropic Foundation 501(c)3 non-profit organization is dedicated to providing pro-bono hair restoration, surgical hair transplants and medical treatments to patients in need. The goal is to use resources to help restore the appearance of men, women and children who have suffered debilitating hair loss through accidents, medical treatments, or other unfortunate causes, so they may regain the confidence they’ve lost in often devastating circumstances. The foundation also supports charitable groups, organizations and events in the areas of education and healthcare in addition to local community initiatives. About Dr. Alan J. Bauman: Alan J. Bauman, M.D. is the founder and chief medical officer of Bauman Medical Hair Transplant and Treatment Center in Boca Raton, FL. At more than 11,000 square feet, his clinic is the world’s largest stand-alone treatment center dedicated exclusively to hair loss. Dr. Bauman has been a full-time hair transplant surgeon since 1997, and has treated over 17,000 patients and performed over 7,000 hair transplant procedures. Dr. Bauman is one of approximately 100 physicians worldwide to achieve board certification from the esteemed American and International Board of Hair Restoration Surgery (ABHRS). He is a Fellow of the International Society of Hair Restoration Surgery (ISHRS), an accepted member of the International Alliance of Hair Restoration Surgeons (IAHRS), recommended by the American Hair Loss Association (AHLA), a member of the Pantene Hair Research Institute and an active lecturer and physician faculty member for numerous medical organizations. Dr. Bauman received his M.D. degree from New York Medical College and surgical residency training at Mt. Sinai Medical Center and Beth Israel Medical Center in New York. As an award-winning philanthropist and founder of the Bauman Philanthropic Foundation, Dr. Bauman is also the proud recipient of the 2015 ‘Guardian Angel’ award presented at Wigs and Wishes by the founder of Friends Are By Your Side, Mr. Martino Cartier. Dr. Bauman also received the Small Business Leader Award presented to him by the Greater Boca Raton Chamber of Commerce thanks in part to his community support and active social contributions and involvement. Dr. Bauman has appeared in print, radio and television as a medical expert and successful early-adopter of the most advanced technologies in the treatment of hair loss. Appearances, interviews and profiles include the Today Show, The Early Show, Good Morning America, Extra, Access Hollywood and Dateline NBC among other TV appearances. Newspaper and Magazine articles and feature stories include The New York Times, Newsweek, Cosmo, Vogue, Allure, O – The Oprah Magazine and Men’s Health among others.
Hatzakis A.,National and Kapodistrian University of Athens |
Sypsa V.,National and Kapodistrian University of Athens |
Paraskevis D.,National and Kapodistrian University of Athens |
Nikolopoulos G.,Hellenic Center for Diseases Prevention and Control |
And 12 more authors.
Addiction | Year: 2015
Aims: To (i) describe an intervention implemented in response to the HIV-1 outbreak among people who inject drugs (PWIDs) in Greece (ARISTOTLE programme), (ii) assess its success in identifying and testing this population and (iii) describe socio-demographic characteristics, risk behaviours and access to treatment/prevention, estimate HIV prevalence and identify risk factors, as assessed at the first participation of PWIDs. Design: A 'seek, test, treat, retain' intervention employing five rounds of respondent-driven sampling. Setting: Athens, Greece (2012-13). Participants: A total of 3320 individuals who had injected drugs in the past 12 months. Intervention: ARISTOTLE is an intervention that involves reaching out to high-risk, hard-to-reach PWIDs ('seek'), engaging them in HIV testing and providing information and materials to prevent HIV ('test') and initiating and maintaining anti-retroviral and opioid substitution treatment for those testing positive ('treat' and 'retain'). Measurements: Blood samples were collected for HIV testing and personal interviews were conducted. Findings: ARISTOTLE recruited 3320 PWIDs during the course of 13.5 months. More than half (54%) participated in multiple rounds, resulting in 7113 visits. HIV prevalence was 15.1%. At their first contact with the programme, 12.5% were on opioid substitution treatment programmes and the median number of free syringes they had received in the preceding month was 0. In the multivariable analysis, apart from injection-related variables, homelessness was a risk factor for HIV infection in male PWIDs [odds ratio (OR)yes versus no=1.89, 95% confidence interval (CI)=1.41, 2.52] while, in female PWIDS, the number of sexual partners (OR for >5 versus one partner in the past year=4.12, 95% CI=1.93, 8.77) and history of imprisonment (OR yes versus no=2.76, 95% CI=1.43, 5.31) were associated with HIV. Conclusions: In Athens, Greece, the ARISTOTLE intervention for identifying HIV-positive people among people who inject drugs (PWID) facilitated rapid identification of a hidden population experiencing an outbreak and provided HIV testing, counselling and linkage to care. According to ARISTOTLE data, the 2011 HIV outbreak in Athens resulted in 15% HIV infection among PWID. Risk factors for HIV among PWID included homelessness in men and history of imprisonment and number of sexual partners in women. © 2015 Society for the Study of Addiction.
News Article | December 22, 2016
After 9 months of treating patients under experimental conditions, Dr. Leonard Grossman has been selected by Bovie Medical as the first and only provider in NYC to offer advanced skin resurfacing treatments with the J-Plasma device or, as Dr. Grossman calls it, the "Tesla Resurfacer." With this innovative technology, Dr. Grossman is now able to entirely eliminate wrinkles, uneven coloring, laxity and many additional signs of aging skin, while significantly reducing the recovery period. “This is the newest and by far the most remarkable and simply the best way to offer patients new, baby like skin," commented Dr. Grossman. According to Dr. Grossman, since the J-Plasma procedure provides natural skin tightening by increasing the skin's collagen production, it is also appropriate and may be used as an alternative to a facelift and a number of other surgical procedures. Specifically, patients are now able to achieve rather palpable skin revitalization in such sensitive and critical areas as forehead and lip lines, skin around the eyes, occasional freckles and even scarring and other areas of discoloration. J-Plasma procedures are typically performed while under twilight IV sedation anesthesia or local anesthesia; the most common procedure time is approximately 35 minutes. To learn more about J-Plasma and to book an appointment with Dr. Grossman, please call his Brooklyn, NY office at 718-934-5500 or visit his website. Dr. Grossman received his medical degree from New York Medical College in 1985. He went on to complete his internship and residency in General Surgery at Beth Israel Medical Center from 1985 to 1988. In 1995 Dr. Grossman completed his Fully Accredited Plastic Surgery Residency at Texas A & M and the Scott & White Memorial Hospital after the completion of his fellowship in Microsurgery at the Montefiore Hospital in the Bronx, NY in 1990 and Burns and Reconstruction fellowship at Jacobi Hospital in the Bronx, NY in 1991. Since performing his first Liposuction under all local anesthesia in 1993, Dr. Grossman realized that the only way to get an ideal or “a near perfect” result in liposuction is to have the procedure done with the patient standing. Since that time, with the compliment of excellent intravenous and local anesthesia, Dr. Grossman’s patients do not have any discomfort, anxiety or unpleasant memories of the procedure. In 1995 Dr. Grossman became the first American Plastic Surgeon to utilize Ultrasound Assisted Liposuction technology that allowed difficult areas on the body (backs and breasts in men and women) to achieve excellent results with minimal down time.
News Article | October 29, 2016
NEW YORK, NY, October 29, 2016-- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has released Top Doctors: New York Metro Area 2016 and has selected Yick Moon Lee, MD for this honor.Top Doctors: New York Metro Area 2016 includes more than 6,500 top primary care physicians and specialists in a twenty county area spanning three states: New York, New Jersey and Connecticut. Selected physicians, including Dr. Lee, represent the top 10% of doctors in the area in 67 medical specialties and subspecialties.Castle Connolly Top Doctors are selected each year by Castle Connolly Medical Ltd. after being nominated by their peers in an online nomination process. Nominations are open to all licensed MDs and DOs; and each year many tens of thousands of physicians cast hundreds of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.About Yick Moon Lee: a short profile by and about the honoree:A former Medical Director of Asian Outreach Services and Associate Director of Pediatric Inpatient Unit at Maimonides Brooklyn Infant and Children's Hospital. Dr. Lee's hospital medicine experience goes back to when he was the Director of the Pediatric Inpatient Unit at Beth Israel Medical Center. He also served as Chief Pediatric Acute Care Unit, Director of Subintership Program for St. George Medical School, and was Pediatric Chief Consultant for New York Eye and Ear Infirmay Hospital. Dr. Lee has a dedicated interest in general pediatrics, emergency/critical care and hospital medicine.For more information about this Castle Connolly Top Doctor, please visit Yick Moon Lee's profile on www.castleconnolly.com Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Lee's recognition: "Roughly ten percent of area physicians were selected for our Top Doctors: New York Metro Area 2016. Being nominated by peers and then selected by our experts is an accomplishment worthy of recognition. The New York Metro area is home to a great number of very high quality medical professionals, yet some stand out. My congratulations to Dr. Lee."To find out more or to contact Dr. Yick Moon Lee of New York, NY, please call call 212-274-1811.This press release was written by American Registry, LLC and Castle Connolly Medical Ltd., with approval by and/or contributions from Yick Moon Lee.Castle Connolly Medical Ltd. identifies Top Doctors in America and provides consumers with detailed information about their education, training and special expertise in their online directory and through print features with magazine and newspaper partner. It is important to note that doctors do not and cannot pay to be included in any Castle Connolly guide or online directory. Learn more http://www.castleconnolly.com American Registry, LLC, recognizes excellence in top businesses and professionals. For more information, search The Registry at http://www.theamericanregistry.com
Okuda M.,York College |
Olfson M.,York College |
Wang S.,York College |
Rubio J.M.,The Zucker Hillside Hospital |
And 2 more authors.
Journal of Traumatic Stress | Year: 2015
This study presents data on the association of intimate partner violence (IPV) perpetration and rates of psychiatric disorders, and other correlates. Data were drawn from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative sample of adults in the United States, 18 years and older, residing in households and group quarters. The sample comprised adults who reported being in a relationship within the past 12 months (N = 25,631). Of these, 1,677 individuals reported perpetrating IPV (4.2% in men, 7.0% in women). Compared to non-IPV perpetrators, IPV perpetrators had greater odds of having any psychiatric disorder, 42.0% and 67.7%, respectively, OR = 2.89, 95% CI [2.51, 3.32]. After adjusting for the effects of nuisance variables, being younger, having an alcohol use disorder, a personality disorder, low levels of social support, and low income were associated with perpetration. Across a wide range of factors, IPV victimization itself had the strongest association with perpetration, AOR = 66.12, 95% CI [55.01, 79.48]. Mental health assessments of IPV perpetrators might offer an opportunity to identify and treat psychiatric disorders and improve the clinical course of conditions that can be affected by ongoing acts of violence. © 2015 International Society for Traumatic Stress Studies.
Goschin S.,Beth Israel Medical Center |
Briggs J.,Beth Israel Medical Center |
Blanco-Lutzen S.,Beth Israel Medical Center |
Cohen L.J.,Beth Israel Medical Center |
Galynker I.,Beth Israel Medical Center
Journal of Affective Disorders | Year: 2013
Objective: Although poor parental bonding is a known risk factor for suicidality, current literature is inconsistent about the relative role of low parental care and parental overprotection, as well as the combination of the two, termed "affectionless control". This review presents the current state of knowledge of the relationship between suicidality and these two aspects of parental bonding. Method: The computerized databases Medline, PubMed, PsychINFO, PsychLit, and Google Scholar were searched using combinations of the following keywords: suicidality, suicide, suicide attempt, suicidal behavior, parental bonding, and parental bonding instrument. Using the results, we reviewed the reports on the relationship between suicidality and parental bonding as measured by validated parental bonding instruments. Results. Twelve papers were analyzed. All of them used the parental bonding instrument (PBI) and one used both the PBI and the object representation inventory (ORI). Most reports agreed that, in mothers, either lack of maternal care and!or overprotection was associated with an increase in suicidal behavior, while in fathers only low care was consistently associated with suicidality. This lack of constancy with regard to the effect of paternal overprotection appears to be due to cultural differences in fathers' role in child rearing. With these differences acknowledged, affectionless control in both parents emerges as the parenting style most strongly associated with suicidal behavior. Common methodological problems included low numbers of subjects, inconsistent control groups, and the lack of a uniform definition of suicidality. Conclusion: Despite methodological limitations, current literature consistently indicates that parental affectionless control is associated with suicidal behavior. Recognizing affectionless control as a risk factor for suicide and developing early interventions aimed at modifying affectionless and overprotective parenting style in families with a history of affective disorders may be effective in reducing suicidal risk. © 2013 Elsevier B.V. All rights reserved.
PubMed | Beth Israel Medical Center
Type: Journal Article | Journal: Journal of affective disorders | Year: 2013
Although poor parental bonding is a known risk factor for suicidality, current literature is inconsistent about the relative role of low parental care and parental overprotection, as well as the combination of the two, termed affectionless control. This review presents the current state of knowledge of the relationship between suicidality and these two aspects of parental bonding.The computerized databases Medline, PubMed, PsychINFO, PsychLit, and Google Scholar were searched using combinations of the following keywords: suicidality, suicide, suicide attempt, suicidal behavior, parental bonding, and parental bonding instrument. Using the results, we reviewed the reports on the relationship between suicidality and parental bonding as measured by validated parental bonding instruments.Twelve papers were analyzed. All of them used the parental bonding instrument (PBI) and one used both the PBI and the object representation inventory (ORI). Most reports agreed that, in mothers, either lack of maternal care and/or overprotection was associated with an increase in suicidal behavior, while in fathers only low care was consistently associated with suicidality. This lack of constancy with regard to the effect of paternal overprotection appears to be due to cultural differences in fathers role in child rearing. With these differences acknowledged, affectionless control in both parents emerges as the parenting style most strongly associated with suicidal behavior. Common methodological problems included low numbers of subjects, inconsistent control groups, and the lack of a uniform definition of suicidality.Despite methodological limitations, current literature consistently indicates that parental affectionless control is associated with suicidal behavior. Recognizing affectionless control as a risk factor for suicide and developing early interventions aimed at modifying affectionless and overprotective parenting style in families with a history of affective disorders may be effective in reducing suicidal risk.